Stem Cells International · 2019 · 35 citations · 32 references
Life SciencesCell BiologyNeuroscienceCell TherapyRegenerative MedicineStem Cell BiologyMesenchymal Stem Cell TherapyNeural Stem Cell BiologyNeural Stem CellsPluripotent Stem CellsStem Cell DifferentiationTissue Engineering With Stem CellsHuman Induced Pluripotent Stem Cell ModelsNeurogenic DifferentiationProgenitor CellsSerum-free Cell CultureSerum-free CultureUmbilical Cord-derived CellsUmbilical Cord-derived Mesenchymal Stem CellsUmbilical Cord-derived Mesenchymal Stromal Cells
Cell therapy has emerged as a promising strategy for treating neurological diseases such as stroke, spinal cord injury, and various neurodegenerative diseases, but both embryonic neural stem cells and human induced Pluripotent Stem Cell- (iPSC-) derived neural stem cells have major limitations which restrict their broad use in these diseases. We want to find a one-step induction method to transdifferentiate the more easily accessible Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSCs) into neural stem/progenitor cells suitable for cell therapy purposes. In this study, UC-MSCs were induced to form neurospheres under a serum-free suspension culture with Epidermal Growth Factor- (EGF-) and basic Fibroblast Growth Factor- (bFGF-) containing medium within 12 hours. These MSC-derived neurospheres can self-renew to form secondary neurospheres and can be readily induced to become neurons and glial cells. Real-time PCR showed significantly upregulated expression of multiple stemness and neurogenic genes after induction. RNA transcriptional profiling study showed that UC-MSC-derived neurospheres had a unique transcriptional profile of their own, with features of both UC-MSCs and neural stem cells. RayBio human growth factor cytokine array analysis showed significantly upregulated expression levels of multiple neurogenic and angiogenic growth factors, skewing toward a neural stem cell phenotype. Thus, we believe that these UC-MSC-derived neurospheres have amenable features of both MSCs and neural stem/progenitor cells and have great potential in future stem cell transplantation clinical trials targeting neurological disorders.
32
Jinquan Cai, Zhixian Wu, Xiumin Xu et al. · Diabetes Care · 2015 · 181 citations
Medicine, Endocrinology, Surgery +17